Cochrane Abstracts
Methotrexate monotherapy versus methotrexate combination therapy with non‐biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis Edited (no change to conclusions), comment added to review
Methotrexate monotherapy versus methotrexate combination therapy with non‐biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis Edited (no change to conclusions), comment added to review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Methotrexate Monotherapy Versus Methotrexate Combination Therapy With Non‐biologic Disease Modifying Anti‐rheumatic Drugs for Rheumatoid Arthritis Edited (no Change to Conclusions), Comment Added to Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432555/all/Methotrexate_monotherapy_versus_methotrexate_combination_therapy_with_non���biologic_disease_modifying_anti���rheumatic_drugs_for_rheumatoid_arthritis_Edited__no_change_to_conclusions___comment_added_to_review. Accessed 28 January 2023.
Methotrexate monotherapy versus methotrexate combination therapy with non‐biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis Edited (no change to conclusions), comment added to review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432555/all/Methotrexate_monotherapy_versus_methotrexate_combination_therapy_with_non���biologic_disease_modifying_anti���rheumatic_drugs_for_rheumatoid_arthritis_Edited__no_change_to_conclusions___comment_added_to_review. Accessed January 28, 2023.
Methotrexate monotherapy versus methotrexate combination therapy with non‐biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis Edited (no change to conclusions), comment added to review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432555/all/Methotrexate_monotherapy_versus_methotrexate_combination_therapy_with_non���biologic_disease_modifying_anti���rheumatic_drugs_for_rheumatoid_arthritis_Edited__no_change_to_conclusions___comment_added_to_review
Methotrexate Monotherapy Versus Methotrexate Combination Therapy With Non‐biologic Disease Modifying Anti‐rheumatic Drugs for Rheumatoid Arthritis Edited (no Change to Conclusions), Comment Added to Review [Internet]. In: Cochrane Abstracts. [cited 2023 January 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432555/all/Methotrexate_monotherapy_versus_methotrexate_combination_therapy_with_non���biologic_disease_modifying_anti���rheumatic_drugs_for_rheumatoid_arthritis_Edited__no_change_to_conclusions___comment_added_to_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Methotrexate monotherapy versus methotrexate combination therapy with non‐biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis Edited (no change to conclusions), comment added to review
ID - 432555
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432555/all/Methotrexate_monotherapy_versus_methotrexate_combination_therapy_with_non���biologic_disease_modifying_anti���rheumatic_drugs_for_rheumatoid_arthritis_Edited__no_change_to_conclusions___comment_added_to_review
DB - Evidence Central
DP - Unbound Medicine
ER -
